

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | leukocyte migration involved in inflammatory response (GO:0002523) | 7.70690292 |
| 2 | leukocyte aggregation (GO:0070486) | 7.59641632 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 6.56791383 |
| 4 | detection of other organism (GO:0098543) | 6.45676390 |
| 5 | detection of bacterium (GO:0016045) | 6.23006672 |
| 6 | response to peptidoglycan (GO:0032494) | 5.87686559 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.79861180 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.79861180 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.79861180 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.79861180 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.79861180 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 5.79861180 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.41973094 |
| 14 | detection of external biotic stimulus (GO:0098581) | 5.34673260 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.30728760 |
| 16 | negative regulation of cell killing (GO:0031342) | 5.30728760 |
| 17 | cellular extravasation (GO:0045123) | 5.12727046 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.02272891 |
| 19 | neutrophil activation (GO:0042119) | 4.95603143 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.85851601 |
| 21 | detection of biotic stimulus (GO:0009595) | 4.75042288 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 4.74664023 |
| 23 | respiratory burst (GO:0045730) | 4.70770775 |
| 24 | * defense response to fungus (GO:0050832) | 4.63034997 |
| 25 | granulocyte activation (GO:0036230) | 4.45620267 |
| 26 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.45117538 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 4.40203832 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.38766661 |
| 29 | microglial cell activation (GO:0001774) | 4.37943932 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.34874844 |
| 31 | response to host immune response (GO:0052572) | 4.34874844 |
| 32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.34680063 |
| 33 | regulation of mast cell degranulation (GO:0043304) | 4.28867173 |
| 34 | immunoglobulin mediated immune response (GO:0016064) | 4.14087654 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.13985444 |
| 36 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 4.09404142 |
| 37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.06752894 |
| 38 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.01220238 |
| 39 | macrophage activation (GO:0042116) | 3.98558214 |
| 40 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.97336970 |
| 41 | response to host (GO:0075136) | 3.97336970 |
| 42 | response to host defenses (GO:0052200) | 3.97336970 |
| 43 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.97239698 |
| 44 | * response to fungus (GO:0009620) | 3.96393144 |
| 45 | neutrophil mediated immunity (GO:0002446) | 3.90394675 |
| 46 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90352207 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.89472940 |
| 48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.85785867 |
| 49 | regulation of gamma-delta T cell activation (GO:0046643) | 3.81981488 |
| 50 | positive regulation of mast cell activation (GO:0033005) | 3.79918477 |
| 51 | regulation of leukocyte degranulation (GO:0043300) | 3.78151926 |
| 52 | regulation of mast cell activation (GO:0033003) | 3.71432769 |
| 53 | chronic inflammatory response (GO:0002544) | 3.63971591 |
| 54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.58504222 |
| 55 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.57599645 |
| 56 | sequestering of metal ion (GO:0051238) | 3.55375133 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.53992684 |
| 58 | leukocyte degranulation (GO:0043299) | 3.52667932 |
| 59 | positive regulation of mast cell degranulation (GO:0043306) | 3.51223144 |
| 60 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.51223144 |
| 61 | myeloid leukocyte mediated immunity (GO:0002444) | 3.48368359 |
| 62 | * neutrophil chemotaxis (GO:0030593) | 3.47395643 |
| 63 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.45520112 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39976609 |
| 65 | regulation of regulated secretory pathway (GO:1903305) | 3.39505851 |
| 66 | * neutrophil migration (GO:1990266) | 3.38476418 |
| 67 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.31483068 |
| 68 | negative regulation of T cell mediated immunity (GO:0002710) | 3.31323160 |
| 69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.28948632 |
| 70 | superoxide anion generation (GO:0042554) | 3.27181815 |
| 71 | B cell mediated immunity (GO:0019724) | 3.26480499 |
| 72 | response to muramyl dipeptide (GO:0032495) | 3.24831991 |
| 73 | negative regulation of interleukin-6 production (GO:0032715) | 3.23882338 |
| 74 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.20892675 |
| 75 | B cell receptor signaling pathway (GO:0050853) | 3.20247862 |
| 76 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.19972127 |
| 77 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.16042871 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.15084678 |
| 79 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.11032771 |
| 80 | defense response to protozoan (GO:0042832) | 3.08300408 |
| 81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.07964967 |
| 82 | regulation of tolerance induction (GO:0002643) | 3.06734226 |
| 83 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.05025056 |
| 84 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.05025056 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.04023306 |
| 86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.99714175 |
| 87 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.99409188 |
| 88 | response to interleukin-15 (GO:0070672) | 2.99158462 |
| 89 | positive regulation of B cell differentiation (GO:0045579) | 2.96984908 |
| 90 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.94346550 |
| 91 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.94195086 |
| 92 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.94195086 |
| 93 | germinal center formation (GO:0002467) | 2.94112244 |
| 94 | activated T cell proliferation (GO:0050798) | 2.93737217 |
| 95 | negative regulation of phagocytosis (GO:0050765) | 2.93572943 |
| 96 | regulation of B cell differentiation (GO:0045577) | 2.92911477 |
| 97 | negative regulation of B cell mediated immunity (GO:0002713) | 2.91511391 |
| 98 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.91511391 |
| 99 | * myeloid leukocyte activation (GO:0002274) | 2.91375364 |
| 100 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.88581972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.88950167 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.46074790 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.30992436 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.08393123 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.54445994 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.42105339 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.29136094 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.28079604 |
| 9 | SPI1_23547873_ChIP-Seq_NB4_Human | 3.11895023 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06225428 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.05221833 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.95033331 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.92887246 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.77907272 |
| 15 | SPI1_23127762_ChIP-Seq_K562_Human | 2.72850097 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65349747 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.59757126 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.55529463 |
| 19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.53053240 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50709118 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.50264780 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47852853 |
| 23 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.38979669 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.38522002 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.27599030 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22945397 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.20580902 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.17682434 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16231664 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.08955621 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.08144778 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03632537 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97681641 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.96626315 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.96456243 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.88600570 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87816626 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84878444 |
| 39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.79619688 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.78280989 |
| 41 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.74303003 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74019831 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69080635 |
| 44 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68494692 |
| 45 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.64487419 |
| 46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63748112 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61256546 |
| 48 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59390981 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.57318605 |
| 50 | MAF_26560356_Chip-Seq_TH2_Human | 1.54999528 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.53546586 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53110555 |
| 53 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.52575173 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52526660 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46776503 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46243816 |
| 57 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45020110 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44487250 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43977098 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43937946 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43735983 |
| 62 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43130869 |
| 63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41987426 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40234988 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39666345 |
| 66 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38285036 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38113614 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36216761 |
| 69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35867326 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34805499 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34545688 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31213551 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29006756 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28993602 |
| 75 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28781817 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.21442515 |
| 77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20812587 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17726037 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 1.16943866 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13940319 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11696950 |
| 82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07891753 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07620310 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07513288 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05349403 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05141781 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05070999 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04968006 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00842402 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00568644 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.99729266 |
| 92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96393889 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96356245 |
| 94 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96020807 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95827060 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92493890 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90007153 |
| 98 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.81040893 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75695876 |
| 100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74408358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.26940028 |
| 2 | MP0003436_decreased_susceptibility_to | 4.18054991 |
| 3 | MP0003303_peritoneal_inflammation | 3.89056908 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.63869383 |
| 5 | MP0002419_abnormal_innate_immunity | 3.52368120 |
| 6 | MP0009785_altered_susceptibility_to | 3.49487081 |
| 7 | MP0005025_abnormal_response_to | 3.13927038 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.78197667 |
| 9 | MP0000685_abnormal_immune_system | 2.70295285 |
| 10 | MP0001800_abnormal_humoral_immune | 2.69414850 |
| 11 | MP0005387_immune_system_phenotype | 2.67527865 |
| 12 | MP0001790_abnormal_immune_system | 2.67527865 |
| 13 | MP0005671_abnormal_response_to | 2.60115529 |
| 14 | MP0002723_abnormal_immune_serum | 2.51305904 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.50789823 |
| 16 | MP0001819_abnormal_immune_cell | 2.47942261 |
| 17 | MP0006082_CNS_inflammation | 2.47440322 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.46453811 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.42588439 |
| 20 | MP0005464_abnormal_platelet_physiology | 2.38597275 |
| 21 | MP0008260_abnormal_autophagy | 2.38301036 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.31533073 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.20959785 |
| 24 | MP0009278_abnormal_bone_marrow | 2.10369655 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.08806488 |
| 26 | MP0003828_pulmonary_edema | 2.02386658 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.96934751 |
| 28 | MP0002405_respiratory_system_inflammati | 1.89862231 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.88346500 |
| 30 | MP0002132_abnormal_respiratory_system | 1.88339813 |
| 31 | MP0002398_abnormal_bone_marrow | 1.87214132 |
| 32 | MP0000716_abnormal_immune_system | 1.82779859 |
| 33 | MP0000465_gastrointestinal_hemorrhage | 1.77777040 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.73060613 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.73060613 |
| 36 | MP0004947_skin_inflammation | 1.64327587 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.59718189 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.59677566 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.57785079 |
| 40 | MP0002722_abnormal_immune_system | 1.56366017 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.55422567 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.50799695 |
| 43 | MP0009764_decreased_sensitivity_to | 1.48232214 |
| 44 | MP0002429_abnormal_blood_cell | 1.47858760 |
| 45 | MP0004883_abnormal_blood_vessel | 1.47685265 |
| 46 | MP0008469_abnormal_protein_level | 1.47227857 |
| 47 | MP0003075_altered_response_to | 1.45723528 |
| 48 | MP0001851_eye_inflammation | 1.45505923 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.39950806 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.39668528 |
| 51 | MP0000858_altered_metastatic_potential | 1.38951087 |
| 52 | MP0003866_abnormal_defecation | 1.34095643 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.31773832 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.31601311 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.27765450 |
| 56 | MP0005451_abnormal_body_composition | 1.25408743 |
| 57 | MP0004381_abnormal_hair_follicle | 1.24872828 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.23657961 |
| 59 | MP0005164_abnormal_response_to | 1.21111985 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.20657027 |
| 61 | MP0004510_myositis | 1.17681474 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.12364472 |
| 63 | MP0005310_abnormal_salivary_gland | 1.12115403 |
| 64 | MP0000343_altered_response_to | 1.09657333 |
| 65 | MP0003690_abnormal_glial_cell | 1.08050091 |
| 66 | MP0005166_decreased_susceptibility_to | 1.00244428 |
| 67 | MP0005083_abnormal_biliary_tract | 0.98964765 |
| 68 | MP0008004_abnormal_stomach_pH | 0.96178768 |
| 69 | MP0009763_increased_sensitivity_to | 0.88881518 |
| 70 | MP0005390_skeleton_phenotype | 0.84677843 |
| 71 | MP0002138_abnormal_hepatobiliary_system | 0.84667378 |
| 72 | MP0003448_altered_tumor_morphology | 0.83657107 |
| 73 | MP0000569_abnormal_digit_pigmentation | 0.83380385 |
| 74 | MP0001853_heart_inflammation | 0.82202979 |
| 75 | MP0001663_abnormal_digestive_system | 0.79237549 |
| 76 | MP0004808_abnormal_hematopoietic_stem | 0.76940597 |
| 77 | MP0000015_abnormal_ear_pigmentation | 0.76484574 |
| 78 | MP0003045_fibrosis | 0.74735165 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.73343406 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73243667 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.71406762 |
| 82 | MP0003795_abnormal_bone_structure | 0.71046552 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.68909050 |
| 84 | MP0002006_tumorigenesis | 0.68017535 |
| 85 | MP0005076_abnormal_cell_differentiation | 0.67225929 |
| 86 | MP0000604_amyloidosis | 0.66478205 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.65813171 |
| 88 | MP0008874_decreased_physiological_sensi | 0.64368012 |
| 89 | MP0000249_abnormal_blood_vessel | 0.62049755 |
| 90 | MP0003566_abnormal_cell_adhesion | 0.58783192 |
| 91 | MP0004130_abnormal_muscle_cell | 0.56870967 |
| 92 | MP0000490_abnormal_crypts_of | 0.56202219 |
| 93 | MP0004264_abnormal_extraembryonic_tissu | 0.56022351 |
| 94 | MP0002133_abnormal_respiratory_system | 0.54020807 |
| 95 | MP0005388_respiratory_system_phenotype | 0.54020807 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.53696521 |
| 97 | MP0001958_emphysema | 0.52317928 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.51458142 |
| 99 | MP0004484_altered_response_of | 0.50975195 |
| 100 | MP0003091_abnormal_cell_migration | 0.50944828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.27596344 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.83573738 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.67870362 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.99117721 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.77069152 |
| 6 | Myositis (HP:0100614) | 5.44095970 |
| 7 | Stomatitis (HP:0010280) | 5.19529632 |
| 8 | Orchitis (HP:0100796) | 4.92247491 |
| 9 | Optic neuritis (HP:0100653) | 4.68531709 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.68531709 |
| 11 | Chronic obstructive pulmonary disease (HP:0006510) | 4.45439612 |
| 12 | Obstructive lung disease (HP:0006536) | 4.45439612 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.33547426 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 4.29701791 |
| 15 | Hypochromic microcytic anemia (HP:0004840) | 4.25060772 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.20977555 |
| 17 | Recurrent skin infections (HP:0001581) | 4.19924619 |
| 18 | Recurrent fungal infections (HP:0002841) | 4.10371732 |
| 19 | Gingivitis (HP:0000230) | 4.01115163 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.95189619 |
| 21 | Meningitis (HP:0001287) | 3.94781566 |
| 22 | Urticaria (HP:0001025) | 3.85860776 |
| 23 | Prolonged bleeding time (HP:0003010) | 3.84596212 |
| 24 | Keratoconjunctivitis sicca (HP:0001097) | 3.64485959 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46419852 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46419852 |
| 27 | Hypochromic anemia (HP:0001931) | 3.42382167 |
| 28 | Encephalitis (HP:0002383) | 3.38445354 |
| 29 | Episodic fever (HP:0001954) | 3.38004946 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.34550618 |
| 31 | Cellulitis (HP:0100658) | 3.33050715 |
| 32 | Increased IgE level (HP:0003212) | 3.30637777 |
| 33 | Gingival bleeding (HP:0000225) | 3.28400591 |
| 34 | Spontaneous hematomas (HP:0007420) | 3.25814104 |
| 35 | Vasculitis (HP:0002633) | 3.17839414 |
| 36 | Epistaxis (HP:0000421) | 3.10268517 |
| 37 | Petechiae (HP:0000967) | 3.10108871 |
| 38 | Anorexia (HP:0002039) | 3.03805835 |
| 39 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.02249975 |
| 40 | Peritonitis (HP:0002586) | 2.99603878 |
| 41 | Chest pain (HP:0100749) | 2.93941453 |
| 42 | Amyloidosis (HP:0011034) | 2.88940950 |
| 43 | Osteomyelitis (HP:0002754) | 2.85758649 |
| 44 | Hemoptysis (HP:0002105) | 2.85506068 |
| 45 | Pulmonary infiltrates (HP:0002113) | 2.79979888 |
| 46 | Leukocytosis (HP:0001974) | 2.77603686 |
| 47 | Arterial thrombosis (HP:0004420) | 2.70339670 |
| 48 | Microcytic anemia (HP:0001935) | 2.64327164 |
| 49 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.58397587 |
| 50 | Recurrent viral infections (HP:0004429) | 2.55616848 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.53172961 |
| 52 | Difficulty running (HP:0009046) | 2.51768335 |
| 53 | Metaphyseal cupping (HP:0003021) | 2.48449543 |
| 54 | Abnormal platelet volume (HP:0011876) | 2.46654411 |
| 55 | Pustule (HP:0200039) | 2.44885923 |
| 56 | T lymphocytopenia (HP:0005403) | 2.44156967 |
| 57 | Granulocytopenia (HP:0001913) | 2.42497877 |
| 58 | Sepsis (HP:0100806) | 2.42144258 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.42068231 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.41796035 |
| 61 | Pulmonary embolism (HP:0002204) | 2.37518160 |
| 62 | Abnormality of iron homeostasis (HP:0011031) | 2.33777681 |
| 63 | Gangrene (HP:0100758) | 2.33549259 |
| 64 | Purpura (HP:0000979) | 2.33293603 |
| 65 | Increased IgM level (HP:0003496) | 2.31081331 |
| 66 | Premature loss of primary teeth (HP:0006323) | 2.30133798 |
| 67 | Hepatosplenomegaly (HP:0001433) | 2.28940471 |
| 68 | Abnormality of T cells (HP:0002843) | 2.28463032 |
| 69 | Increased serum ferritin (HP:0003281) | 2.27325034 |
| 70 | Panhypogammaglobulinemia (HP:0003139) | 2.26251064 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.23893313 |
| 72 | Polycythemia (HP:0001901) | 2.20929156 |
| 73 | Abnormality of the peritoneum (HP:0002585) | 2.15295292 |
| 74 | Muscle fiber splitting (HP:0003555) | 2.15164153 |
| 75 | Colitis (HP:0002583) | 2.14406267 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.14276533 |
| 77 | Abnormality of T cell physiology (HP:0011840) | 2.13126199 |
| 78 | Skin ulcer (HP:0200042) | 2.10169263 |
| 79 | Hypergammaglobulinemia (HP:0010702) | 2.09745257 |
| 80 | Recurrent pneumonia (HP:0006532) | 2.02791932 |
| 81 | Abnormality of glycolipid metabolism (HP:0010969) | 1.98736952 |
| 82 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.98736952 |
| 83 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.98736952 |
| 84 | Vertigo (HP:0002321) | 1.97327504 |
| 85 | Lymphopenia (HP:0001888) | 1.94728097 |
| 86 | Abnormality of the endocardium (HP:0004306) | 1.94188484 |
| 87 | Eosinophilia (HP:0001880) | 1.92324949 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 1.89631480 |
| 89 | Glomerulopathy (HP:0100820) | 1.89154460 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89128629 |
| 91 | Skin rash (HP:0000988) | 1.87691344 |
| 92 | Slow saccadic eye movements (HP:0000514) | 1.87160744 |
| 93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86987230 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.86277039 |
| 95 | Menorrhagia (HP:0000132) | 1.83797306 |
| 96 | Toxemia of pregnancy (HP:0100603) | 1.83279027 |
| 97 | Acne (HP:0001061) | 1.82525807 |
| 98 | Disinhibition (HP:0000734) | 1.80710651 |
| 99 | Loss of speech (HP:0002371) | 1.80272567 |
| 100 | Keratitis (HP:0000491) | 1.80131595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.49896986 |
| 2 | MAP2K3 | 3.94565756 |
| 3 | IRAK4 | 3.39203276 |
| 4 | BLK | 3.12353004 |
| 5 | GRK6 | 2.88283806 |
| 6 | CSK | 2.83161511 |
| 7 | FES | 2.79965035 |
| 8 | MAP4K1 | 2.78987373 |
| 9 | TYK2 | 2.41916896 |
| 10 | ERN1 | 2.40343757 |
| 11 | TNK2 | 2.32462844 |
| 12 | FGR | 2.29399565 |
| 13 | ZAP70 | 2.16027821 |
| 14 | TAOK1 | 2.06180313 |
| 15 | PRPF4B | 2.04251952 |
| 16 | BTK | 2.01697681 |
| 17 | MAP3K3 | 1.97114344 |
| 18 | MAP3K6 | 1.93632157 |
| 19 | EPHB1 | 1.78074675 |
| 20 | SYK | 1.77309693 |
| 21 | HCK | 1.73936533 |
| 22 | JAK3 | 1.68195552 |
| 23 | MAP3K11 | 1.64408188 |
| 24 | MAP3K14 | 1.50744465 |
| 25 | LYN | 1.49122649 |
| 26 | JAK2 | 1.43101222 |
| 27 | TEC | 1.41286375 |
| 28 | YES1 | 1.38161069 |
| 29 | TXK | 1.37575978 |
| 30 | IKBKE | 1.32713029 |
| 31 | MAP3K1 | 1.29451713 |
| 32 | CSF1R | 1.20231595 |
| 33 | KSR2 | 1.19862980 |
| 34 | MAP3K13 | 1.14999284 |
| 35 | TBK1 | 1.14749764 |
| 36 | SIK3 | 1.14420221 |
| 37 | JAK1 | 1.10382807 |
| 38 | ITK | 1.09650078 |
| 39 | TAOK2 | 1.06173942 |
| 40 | LCK | 1.06084600 |
| 41 | MARK3 | 1.03840471 |
| 42 | KIT | 1.03038073 |
| 43 | MAP2K4 | 1.02758286 |
| 44 | IRAK1 | 1.00826518 |
| 45 | BMPR2 | 0.99126408 |
| 46 | MARK2 | 0.97338494 |
| 47 | IRAK2 | 0.92670940 |
| 48 | MATK | 0.90280004 |
| 49 | MAP3K5 | 0.88028105 |
| 50 | MAP3K2 | 0.85288770 |
| 51 | TAOK3 | 0.85040565 |
| 52 | PTK6 | 0.83906791 |
| 53 | PDK1 | 0.83171105 |
| 54 | PTK2B | 0.82487724 |
| 55 | PIK3CG | 0.82262818 |
| 56 | PDPK1 | 0.80400432 |
| 57 | CDK19 | 0.79213141 |
| 58 | LRRK2 | 0.78886575 |
| 59 | PRKD2 | 0.76751753 |
| 60 | STK10 | 0.74770483 |
| 61 | IKBKB | 0.74012796 |
| 62 | TESK2 | 0.73212336 |
| 63 | FYN | 0.73051303 |
| 64 | MAP2K6 | 0.67602695 |
| 65 | SIK2 | 0.61682501 |
| 66 | TGFBR2 | 0.58698320 |
| 67 | RET | 0.58478582 |
| 68 | MAP3K7 | 0.57642930 |
| 69 | STK11 | 0.56669899 |
| 70 | MAPK12 | 0.56642567 |
| 71 | SGK3 | 0.53443452 |
| 72 | DAPK2 | 0.52668930 |
| 73 | EPHA3 | 0.49581404 |
| 74 | RPS6KC1 | 0.48856634 |
| 75 | RPS6KL1 | 0.48856634 |
| 76 | RAF1 | 0.46903229 |
| 77 | FGFR3 | 0.45903817 |
| 78 | KSR1 | 0.44755549 |
| 79 | TRIB3 | 0.40829003 |
| 80 | PIM1 | 0.40786493 |
| 81 | MAPK7 | 0.40708532 |
| 82 | MAPKAPK2 | 0.40553411 |
| 83 | RPS6KA6 | 0.40258346 |
| 84 | DYRK1B | 0.39894268 |
| 85 | CDC42BPA | 0.38609081 |
| 86 | PRKCQ | 0.37889196 |
| 87 | BMX | 0.36121893 |
| 88 | PRKCD | 0.35838610 |
| 89 | SGK2 | 0.34390305 |
| 90 | HIPK2 | 0.34105635 |
| 91 | SMG1 | 0.33898135 |
| 92 | CLK1 | 0.30971803 |
| 93 | PRKCZ | 0.29517031 |
| 94 | WNK1 | 0.28962056 |
| 95 | ABL1 | 0.28240898 |
| 96 | DYRK3 | 0.27340682 |
| 97 | MOS | 0.27167828 |
| 98 | PRKG2 | 0.25777316 |
| 99 | GRK7 | 0.25776596 |
| 100 | STK38 | 0.25703159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.29354113 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.24373872 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.20005337 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.92898600 |
| 5 | Tuberculosis_Homo sapiens_hsa05152 | 2.28382698 |
| 6 | Malaria_Homo sapiens_hsa05144 | 2.18636796 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18490191 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.17511260 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.17450967 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.04476858 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.03780982 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.00432240 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.82662273 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.75344089 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.69393606 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.67510917 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.67023453 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.61542892 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54831855 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54249834 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.53341794 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.48176760 |
| 23 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.47480726 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.45294773 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40478045 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.39520045 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.38640299 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34078010 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30138318 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.29833001 |
| 31 | Platelet activation_Homo sapiens_hsa04611 | 1.29536085 |
| 32 | Salmonella infection_Homo sapiens_hsa05132 | 1.25056948 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.23992394 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.21738540 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.21291553 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20978293 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19433664 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19259065 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16583720 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.13953749 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13037215 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11727193 |
| 43 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11628709 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.10700210 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.04218742 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01332390 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.96353433 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95163656 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94172920 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93712758 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93041136 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.91448559 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.86391772 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86367991 |
| 55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84642508 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84231488 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 0.80153751 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.79614031 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77282768 |
| 60 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76902422 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76774919 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75168809 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73804776 |
| 64 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73618922 |
| 65 | Endocytosis_Homo sapiens_hsa04144 | 0.73458654 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72927678 |
| 67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.71826625 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71720792 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70213399 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69958078 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.69178168 |
| 72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67195618 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66642958 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63811629 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62318277 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59408733 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58689728 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58174570 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56076865 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55706051 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55465159 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53858759 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53688619 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.52840629 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.52036027 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52031959 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51714107 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51504397 |
| 89 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49327699 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44972889 |
| 91 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43966397 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42915893 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.42686751 |
| 94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42294349 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41789560 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41320559 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40560949 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38910624 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38731999 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38199196 |

